Akoya Biosciences, Inc. (AKYA) stock rallied over 6.87% intraday to trade at $14.00 a share on NASDAQ. The stock opened with a gain of 8.11% at $13.04 and touched an intraday high of $14.09, rising 6.87% against the last close of $13.1. The stock went to a low of $13.04 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue54.92 Million
5Y Sales Change-
Fiscal Year Ends2021-12-30
IndustryLife Sciences Tools and Services
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research. It offers single-cell resolution with spatial context that provides a wealth of information to visualize tissue organization and disease pathology on a molecular level to understand disease progression and treatment response. The company also provides PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen, or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. In addition, it offers Proxima, a cloud-based platform designed to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
Akoya Biosciences, Inc. (NASDAQ: AKYA) stock price is $14 as of the last check on Wednesday, July 6. During the trading session, AKYA stock reached the peak price of $14.09 while $13.04 was the lowest point it dropped to.
The NASDAQ listed AKYA is part of Life Sciences Tools and Services industry that operates in the broader Health Care sector. Akoya Biosciences, Inc. , a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research.
Dr. Niro Ramachandran Ph.D.
Chief Bus. Officer
Mr. Brian McKelligon
Pres, CEO & Director
Dr. Garry P. Nolan Ph.D.
Co-Founder, Independent Director & Head of the Scientific Advisory Board
Mr. Joseph S. Driscoll
Chief Financial Officer
AKYA stock traded closed the last session at $14, which is $0.90 or 6.87% lower than its previous close of $13.1. AKYA's current trading price is 74.56% lower than its 52-week high of $21.84 where as its distance from 52-week low of 8.02% is -35.90%.
Number of AKYA employees currently stands at -. AKYA operates from 100 Campus Drive, 6th Floor, Marlborough, MA 01752, United States.
Official Webiste of $AKYA is: https://www.akoyabio.com
AKYA stock volume for the day was 195,386 shares while in the previous session number of AKYA shares traded was 195,806 . The average number of AKYA shares traded daily for last 3 months was 92.67 Thousands.
The percentage change in AKYA stock occurred in the recent session was 6.87% while the dollar amount for the price change in AKYA stock was $0.90.
In the recent session, the day high for AKYA stock was $14.09 while the low for AKYA stock touched on the day was $13.04.
The market value of AKYA currently stands at 512.26 Million with its latest stock price at $14 and 37.47 Million of its shares outstanding.